MEDIF.US Medipharm Labs Corp

Healthcare Pharmaceuticals USA Stocks
0.0440 USD
Close of Nov 17, 2026
0.0400 0.0760
Market cap
USD 18.8M
P/E
-
P/B
0.81x
ROE
-4.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is MEDIF.US undervalued?

Graham number

The Graham number of Medipharm Labs Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Medipharm Labs Corp fundamental analysis

No fundamental analysis for Medipharm Labs Corp yet.

Medipharm Labs Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Medipharm Labs Corp

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distrib…

Full company profile